Barrett’s esophagus as a marker for increased risk for esophageal cancer and cardiorespiratory disease

• References

• 1 Caygill CPJ, Charlett A, Wall CM et al. Mortality in Barrett’s esophagus: three decades at a single center. Endoscopy 2012; 44: 892-898
• 2 Forte JG. The gastric parietal cell: at home and abroad. Eur Surg 2010; 42: 134-148
• 3 Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010; 42: 781-789
• 4 Lyday WD, Corbett FS, Kuperman DA et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010; 42: 272-278
• 5 Shaheen NJ, Peery F, Hawes RH et al. Quality of life following radiofrequency ablation of dysplastic Barrett’s esophagus. Endoscopy 2010; 42: 790-799
• 6 Sikkema M, Looman CWN, Steyerberg EW et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol 2011; 106: 1231-1238
• 7 Tsesmeli N, Coumaros D. The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery. Endoscopy 2010; 42: 155-162